Cargando…

Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction

How circulating inflammatory mediators change upon sepsis progression has not been studied. We studied the follow-up changes of circulating vasoactive peptides and cytokines until the improvement or the worsening of a patient and progression into specific organ dysfunctions. In a prospective study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ioakeimidou, A., Pagalou, E., Kontogiorgi, M., Antoniadou, E., Kaziani, K., Psaroulis, K., Giamarellos-Bourboulis, E. J., Prekates, A., Antonakos, N., Lassale, P., Gogos, C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101577/
https://www.ncbi.nlm.nih.gov/pubmed/28455780
http://dx.doi.org/10.1007/s10096-017-2988-6
_version_ 1783511654426738688
author Ioakeimidou, A.
Pagalou, E.
Kontogiorgi, M.
Antoniadou, E.
Kaziani, K.
Psaroulis, K.
Giamarellos-Bourboulis, E. J.
Prekates, A.
Antonakos, N.
Lassale, P.
Gogos, C.
author_facet Ioakeimidou, A.
Pagalou, E.
Kontogiorgi, M.
Antoniadou, E.
Kaziani, K.
Psaroulis, K.
Giamarellos-Bourboulis, E. J.
Prekates, A.
Antonakos, N.
Lassale, P.
Gogos, C.
author_sort Ioakeimidou, A.
collection PubMed
description How circulating inflammatory mediators change upon sepsis progression has not been studied. We studied the follow-up changes of circulating vasoactive peptides and cytokines until the improvement or the worsening of a patient and progression into specific organ dysfunctions. In a prospective study, concentrations of tumor necrosis factor-alpha (TNFα), interleukin (IL)-6, IL-8, IL-10, interferon-gamma (IFNγ), endocan and angiopoietin-2 (Ang-2) were measured in serum by an enzyme immunoassay in 175 patients at baseline; this was repeated within 24 h upon progression into new organ dysfunction (n = 141) or improvement (n = 34). Endocan and Ang-2 were the only parameters that were significantly increased among patients who worsened. Any increase of endocan was associated with worsening with odds ratio 16.65 (p < 0.0001). This increase was independently associated with progression into acute respiratory distress syndrome (ARDS) as shown after logistic regression analysis (odds ratio 2.91, p: 0.002). Changes of circulating cytokines do not mediate worsening of the critically ill patients. Instead endocan and Ang2 are increased and this may be interpreted as a key-playing role in the pathogenesis of ARDS and septic shock. Any increase of endocan is a surrogate of worsening of the clinical course.
format Online
Article
Text
id pubmed-7101577
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-71015772020-03-31 Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction Ioakeimidou, A. Pagalou, E. Kontogiorgi, M. Antoniadou, E. Kaziani, K. Psaroulis, K. Giamarellos-Bourboulis, E. J. Prekates, A. Antonakos, N. Lassale, P. Gogos, C. Eur J Clin Microbiol Infect Dis Original Article How circulating inflammatory mediators change upon sepsis progression has not been studied. We studied the follow-up changes of circulating vasoactive peptides and cytokines until the improvement or the worsening of a patient and progression into specific organ dysfunctions. In a prospective study, concentrations of tumor necrosis factor-alpha (TNFα), interleukin (IL)-6, IL-8, IL-10, interferon-gamma (IFNγ), endocan and angiopoietin-2 (Ang-2) were measured in serum by an enzyme immunoassay in 175 patients at baseline; this was repeated within 24 h upon progression into new organ dysfunction (n = 141) or improvement (n = 34). Endocan and Ang-2 were the only parameters that were significantly increased among patients who worsened. Any increase of endocan was associated with worsening with odds ratio 16.65 (p < 0.0001). This increase was independently associated with progression into acute respiratory distress syndrome (ARDS) as shown after logistic regression analysis (odds ratio 2.91, p: 0.002). Changes of circulating cytokines do not mediate worsening of the critically ill patients. Instead endocan and Ang2 are increased and this may be interpreted as a key-playing role in the pathogenesis of ARDS and septic shock. Any increase of endocan is a surrogate of worsening of the clinical course. Springer Berlin Heidelberg 2017-04-28 2017 /pmc/articles/PMC7101577/ /pubmed/28455780 http://dx.doi.org/10.1007/s10096-017-2988-6 Text en © Springer-Verlag Berlin Heidelberg 2017 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Ioakeimidou, A.
Pagalou, E.
Kontogiorgi, M.
Antoniadou, E.
Kaziani, K.
Psaroulis, K.
Giamarellos-Bourboulis, E. J.
Prekates, A.
Antonakos, N.
Lassale, P.
Gogos, C.
Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction
title Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction
title_full Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction
title_fullStr Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction
title_full_unstemmed Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction
title_short Increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction
title_sort increase of circulating endocan over sepsis follow-up is associated with progression into organ dysfunction
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7101577/
https://www.ncbi.nlm.nih.gov/pubmed/28455780
http://dx.doi.org/10.1007/s10096-017-2988-6
work_keys_str_mv AT ioakeimidoua increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction
AT pagaloue increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction
AT kontogiorgim increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction
AT antoniadoue increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction
AT kazianik increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction
AT psaroulisk increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction
AT giamarellosbourboulisej increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction
AT prekatesa increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction
AT antonakosn increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction
AT lassalep increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction
AT gogosc increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction
AT increaseofcirculatingendocanoversepsisfollowupisassociatedwithprogressionintoorgandysfunction